Cannell & Spears’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$501K Buy
26,261
+825
+3% +$18.2K 0.01% 301
2025
Q4
$615K Hold
25,436
0.01% 273
2025
Q3
$649K Sell
25,436
-159
-0.6% -$3.77K 0.01% 268
2025
Q2
$551K Hold
25,595
0.01% 279
2025
Q1
$585K Sell
25,595
-400
-2% -$10.5K 0.01% 271
2024
Q4
$675K Sell
25,995
-1,322
-5% -$32.9K 0.01% 266
2024
Q3
$684K Hold
27,317
0.01% 266
2024
Q2
$585K Sell
27,317
-35
-0.1% -$679 0.01% 257
2024
Q1
$507K Hold
27,352
0.01% 281
2023
Q4
$444K Hold
27,352
0.04% 143
2023
Q3
$378K Sell
27,352
-1,450
-5% -$22.8K 0.03% 149
2023
Q2
$637K Sell
28,802
-280
-1% -$5.9K 0.05% 117
2023
Q1
$633K Hold
29,082
0.06% 120
2022
Q4
$529K Hold
29,082
0.05% 127
2022
Q3
$662K Sell
29,082
-270
-0.9% -$5.78K 0.07% 104
2022
Q2
$405K Buy
29,352
+6,000
+26% +$88K 0.04% 146
2022
Q1
$531K Buy
23,352
+209
+0.9% +$5.5K 0.04% 143
2021
Q4
$863K Buy
23,143
+614
+3% +$26.4K 0.06% 110
2021
Q3
$953K Sell
22,529
-4,102
-15% -$198K 0.07% 99
2021
Q2
$1.19M Sell
26,631
-560
-2% -$19.7K 0.09% 92
2021
Q1
$979K Buy
27,191
+48
+0.2% +$1.9K 0.08% 92
2020
Q4
$1.08M Buy
27,143
+1,071
+4% +$36.5K 0.09% 88
2020
Q3
$755K Hold
26,072
0.07% 98
2020
Q2
$426K Buy
26,072
+210
+0.8% +$2.9K 0.04% 130
2020
Q1
$246K Buy
25,862
+7,795
+43% +$107K 0.03% 170
2019
Q4
$292K Buy
18,067
+4,467
+33% +$72.6K 0.03% 149
2019
Q3
$226K Hold
13,600
0.03% 161
2019
Q2
$231K Hold
13,600
0.03% 159
2019
Q1
$243K Buy
+13,600
New +$216K 0.03% 151

Other funds holding BLFS